about
Advanced soft-tissue sarcoma and treatment options: critical appraisal of trabectedinThe value of trabectedin in the treatment of soft tissue sarcomaPatterns of Chromosomal Aberrations in Solid TumorsSequencing Overview of Ewing Sarcoma: A Journey across Genomic, Epigenomic and Transcriptomic LandscapesTrabectedin and plitidepsin: drugs from the sea that strike the tumor microenvironmentTrabectedin for advanced soft tissue sarcomas: optimizing useCurrent classification, treatment options, and new perspectives in the management of adipocytic sarcomasTrabectedin in soft tissue sarcomasTrabectedin and Campthotecin Synergistically Eliminate Cancer Stem Cells in Cell-of-Origin Sarcoma ModelsClinical utility of trabectedin for the treatment of ovarian cancer: current evidence.Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma.Advances in the targeted therapy of liposarcoma.Trabectedin therapy as an emerging treatment strategy for recurrent platinum-sensitive ovarian cancerA comprehensive safety evaluation of trabectedin and drug-drug interactions of trabectedin-based combinations.Normal and functional TP53 in genetically stable myxoid/round cell liposarcoma.Mechanism of action of trabectedin in desmoplastic small round cell tumor cells.Trabectedin in advanced synovial sarcomas: a multicenter retrospective study from four European institutions and the Italian Rare Cancer NetworkPrimary Retroperitoneal Myxoid LiposarcomasEfficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial.Current Concepts in Non-Gastrointestinal Stromal Tumor Soft Tissue Sarcomas: A Primer for Radiologists.Phase III Soft Tissue Sarcoma Trials: Success or Failure?Trabectedin, a drug acting on both cancer cells and the tumour microenvironment.Benign and malignant tumors of the foot and ankle.Trabectedin for the treatment of breast cancer.Unique features of trabectedin mechanism of action.Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms.Gene and microRNA modulation upon trabectedin treatment in a human intrahepatic cholangiocarcinoma paired patient derived xenograft and cell line.Treatment of advanced soft tissue sarcoma: efficacy and safety of trabectedin, a multitarget agent, and update on other systemic therapeutic options.Efficacy of Trabectedin in Patients with Advanced Translocation-Related Sarcomas: Pooled Analysis of Two Phase II Studies.The safety and efficacy of trabectedin for the treatment of liposarcoma or leiomyosarcoma.Liposarcoma: Multimodality Management and Future Targeted Therapies.The histological variants of liposarcoma: predictive MRI findings with prognostic implications, management, follow-up, and differential diagnosis.Drug-induced hepatotoxicity in cancer patients - implication for treatment.ERG deregulation induces IGF-1R expression in prostate cancer cells and affects sensitivity to anti-IGF-1R agents.Tumor calcification: a new response pattern of myxoid liposarcoma to trabectedin.Pharmacological therapies for Liposarcoma.Newer medical therapies for metastatic soft tissue sarcoma.Synovial Sarcoma: Advances in Diagnosis and Treatment Identification of New Biologic Targets to Improve Multimodal Therapy.Synergistic Effect of Trabectedin and Olaparib Combination Regimen in Breast Cancer Cell Lines.Targeting the EWS-FLI1 transcription factor in Ewing sarcoma.
P2860
Q26738346-D409C61A-A5BB-424B-B8EC-9CA4970D2A8DQ26772855-3D42AEBE-541A-45F8-9E0D-02A7A753334BQ26786127-0127836B-A460-4E72-9064-4DD6928B4DF3Q26801785-79480677-5C3B-4E51-9B72-45789EF57199Q26851658-8A7849C1-C9C9-453B-8886-EA2E848EE13CQ26860365-FBFECAAF-6960-4807-9285-9C3FEE9870FCQ28076210-FE6734C9-D6ED-40CD-8E44-E41BD398BCE7Q28085505-C7E3DB92-E661-4BC1-A6BB-F84F4D3F52A8Q33649056-740279AB-115D-4DC6-AE62-5053A925F53EQ33921802-039A4B0D-A8D4-47B1-91EA-F0F9DB014790Q34674564-F04CAEFF-04F2-4BAF-A791-D501EDD9B928Q34952133-1A5DFB31-E30A-4CF9-A245-529871905CD6Q34996149-11F7BCA1-403F-4D1A-B045-B21DC604FB98Q35246995-B86A8CE0-E124-4377-8C4C-068C5A56A679Q35416886-EB50ECFB-985C-4709-BA3E-018DAD671AB8Q36272148-F183DF7B-0359-4D13-9B29-548C08926F2AQ36514001-D939EC99-258C-4626-93E8-5E301206AD1DQ37268602-65D114EC-1293-41E7-BFB0-BE0E8C9DD617Q37350801-C1371DA6-CC89-4B9C-BCAF-6AC2079A32A9Q37589535-4511A553-6968-40C6-A175-5A3E3613BE88Q37716872-EFEC1638-E577-4D11-B21F-ADCAF00E5D2CQ38206366-B0B72715-1B0F-4A02-94C4-2AE262CB5B53Q38623700-A685C227-02D4-41F7-A3BF-B0798D757B6CQ38642314-73065F61-79D7-49D2-8DA8-506FD0A2F7CAQ38669051-33E74C55-8F2B-464F-906D-D8F53D8A3ED1Q38722106-0A7F80A3-62D4-4A27-8061-716A69F59D7FQ38728270-90C7206E-7E4F-42A2-9F46-21D6F15B5785Q38731757-01D56D91-D520-40EF-AD85-7B67A5BDC58BQ38773772-01E41C2F-B64A-42C0-B613-DB81C1DD0847Q38797843-82CF54F0-7D25-4E71-8366-DEFEB425BD21Q38824691-BB8B74DF-C6FD-4966-AF73-C7319C989EB4Q38840866-E3DE91C4-B118-4243-8D7B-8F6771786D9FQ38845891-DF2D92BF-4139-409E-8B3D-4CE2B8DDBC23Q38883101-D50A622F-C98E-4D48-8D09-084C204CCCABQ38964429-E7A56886-5270-4E7F-8D55-5908333ACE7DQ38991731-0467F7A1-5F54-4EE9-B631-DD4031D73970Q39012067-00EFBBF8-248D-4ACD-B6BC-4DD7C7FB17F3Q39233440-7DBF1DE8-680D-4A55-8E6E-D34376EE0994Q40105033-5FAE2E01-C392-4A08-BA8B-F1FEA651E54CQ41159521-543650B7-52A5-4AE1-9557-239C3FBB82A9
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Mode of action of trabectedin in myxoid liposarcomas.
@en
Mode of action of trabectedin in myxoid liposarcomas.
@nl
type
label
Mode of action of trabectedin in myxoid liposarcomas.
@en
Mode of action of trabectedin in myxoid liposarcomas.
@nl
prefLabel
Mode of action of trabectedin in myxoid liposarcomas.
@en
Mode of action of trabectedin in myxoid liposarcomas.
@nl
P2093
P2860
P50
P356
P1433
P1476
Mode of action of trabectedin in myxoid liposarcomas
@en
P2093
C M Galmarini
J M F Sousa-Faro
R Mantovani
S A Licandro
S Di Giandomenico
P2860
P2888
P304
P356
10.1038/ONC.2013.462
P407
P50
P577
2013-11-11T00:00:00Z
P5875
P6179
1047744564